Copyright
©The Author(s) 2022.
World J Gastroenterol. Jul 7, 2022; 28(25): 2920-2936
Published online Jul 7, 2022. doi: 10.3748/wjg.v28.i25.2920
Published online Jul 7, 2022. doi: 10.3748/wjg.v28.i25.2920
Gene | Positive rate of pathogenic gene mutation sites | χ2 | P value | |
Preoperative feces | Normal control group | |||
TP53 | 37.04% (10/27) | 0 | 7.328 | 0.007 |
APC | 11.11% (3/27) | 0 | 0.878 | 0.349 |
KRAS | 25.93% (7/27) | 0 | 4.219 | 0.040 |
PIK3CA | 3.70% (1/27) | 0 | Fisher exact test | 1 |
FBXW7 | 3.70% (1/27) | 0 | Fisher exact test | 1 |
GNAS | 3.70% (1/27) | 0 | Fisher exact test | 1 |
PTEN | 3.70% (1/27) | 0 | Fisher exact test | 1 |
ABL1 | 3.70% (1/27) | 0 | Fisher exact test | 1 |
PDGFRA | 3.70% (1/27) | 0 | Fisher exact test | 1 |
- Citation: He SY, Li YC, Wang Y, Peng HL, Zhou CL, Zhang CM, Chen SL, Yin JF, Lin M. Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis. World J Gastroenterol 2022; 28(25): 2920-2936
- URL: https://www.wjgnet.com/1007-9327/full/v28/i25/2920.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i25.2920